<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="publisher-id">abd</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26734873</article-id>
      <article-id pub-id-type="pmc">4689080</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20153966</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Epidermolytic Hyperkeratosis - case report<xref ref-type="fn" rid="fn1">*</xref>
</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Hayashida</surname>
            <given-names>Marcos Takeyoshi</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mitsui</surname>
            <given-names>Grasiela Lissa</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>dos Reis</surname>
            <given-names>Natalia Ivanoff</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
          <xref ref-type="corresp" rid="c1"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Fantinato</surname>
            <given-names>Giovana</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Jord&#xE3;o Neto</surname>
            <given-names>Domingos</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Mercante</surname>
            <given-names>Ana Maria da Cunha</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <aff id="aff1"><label>1</label>Hospital Heliop&#xF3;lis - S&#xE3;o Paulo (SP), Brazil</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1">MAILING ADDRESS: Natalia Ivanoff dos Reis, Rua: 24, 862 -
Centro, 14780-090 - Barretos - SP Brazil. E-mail:
<email>natalia.ivanoff@gmail.com</email></corresp>
        <fn fn-type="conflict">
          <p>Conflict of Interest: None</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Nov-Dec</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Nov-Dec</season>
        <year>2015</year>
      </pub-date>
      <volume>90</volume>
      <issue>6</issue>
      <fpage>888</fpage>
      <lpage>891</lpage>
      <history>
        <date date-type="received">
          <day>20</day>
          <month>8</month>
          <year>2014</year>
        </date>
        <date date-type="accepted">
          <day>16</day>
          <month>9</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9;2015 by Anais Brasileiros de
Dermatologia</copyright-statement>
        <copyright-year>2015</copyright-year>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/4.0/">
          <license-p>This is an Open Access article distributed under the terms of
the Creative Commons Attribution License, which permits unrestricted
use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Epidermolytic hipercetarose is a rare genodermatosis, with a prevalence of
1:100.000 to 1:300.000, with autosomal dominant inheritance. We report the
case of a 5 year old girlwho presented an hypertrophic verrucous plaques in
the neck, under arm, buttocks, knees, pelvis, legs, dorsum of the right
foot and elbows. Histological examination of the skin lesions showed
typical changes of epidermolytic hyperkeratosis. Because it is an autosomal
dominant disorder with complete penetrance, the individual carrying the
mutation will necessarily develop the disease. However, in 50% of cases
postzygotic mutation occur. The case report emphasizes early diagnosis and
differential diagnoses with ichthyosis and other bullous diseases of
childhood, as well as discussing the therapeutic possibilities.</p>
      </abstract>
      <kwd-group>
        <kwd>Acitretin</kwd>
        <kwd>Hyperkeratosis, epidermolytic</kwd>
        <kwd>Ichthyosis bullosa of siemens</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Epidermolytic hyperkeratosis (EHK), bullous congenital ichthyosiform erythroderma
of Brocq, ichthyosis bullosa of Siemens or ichthyosis hystrix Curth-Macklin are
synonyms for the same disease.<sup><xref rid="r1" ref-type="bibr">1</xref></sup>
It is a rare dermatosis, with prevalence of 1:100,000 to 1:300,000, of autosomal
dominant inheritance, which affects both sexes equally with high rates of
spontaneous mutations occurring in up to 50% of the cases.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref></sup> A case of epidermolytic hyperkeratosis in a female
child is described, whose diagnosis was confirmed both clinically and by means
of a biopsy.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>Female patient, 5 years and 3 months old, from the state of Bahia. She was born
through c-section with no complications. She is the only child of healthy and
non-consanguineous parents. Her mother reported that at the time of birth she
noticed the presence of blisters and pruritic lesions all over the patient's
body and used urea-based topical drugs. At the dermatological examination we
observed verrucous and hyperchromic plaques in the cervical region, axillae,
buttocks, knees, pelvic waist, legs, dorsum of right foot and elbows (<xref ref-type="fig" rid="f1">Figures 1</xref> to <xref ref-type="fig" rid="f4">4</xref>). The histopathological examination demonstrated epidermis with
hyperkeratosis, papillomatosis, hypergranulosis, presence of vacuolated
keratinocytes, some with keratohyalin granules in the upper third of stratum
malpighi, consistent with clinical hypothesis of epidermolytic hyperkeratosis
(<xref ref-type="fig" rid="f5">Figures 5</xref>).</p>
      <fig id="f1" orientation="portrait" position="float">
        <label>Figure 1</label>
        <caption>
          <p>Verrucous and hyperchromic plaques in axillary regions</p>
        </caption>
        <graphic xlink:href="abd-90-06-0888-g01"/>
      </fig>
      <fig id="f4" orientation="portrait" position="float">
        <label>Figure 4</label>
        <caption>
          <p>Verrucous and hyperchromic plaques involving buttocks and posterior
region of thighs following Blaschko lines</p>
        </caption>
        <graphic xlink:href="abd-90-06-0888-g04"/>
      </fig>
      <fig id="f5" orientation="portrait" position="float">
        <label>Figure 5</label>
        <caption>
          <p>A. HE 100x Epidermis with hyperkeratosis, papillomatosis,
hypergranulosis and vacuolated keratinocytes in upper third of
epithelium B. HE 400x Keratohyalin granules in vacuolated
keratinocytes in upper third of epidermis</p>
        </caption>
        <graphic xlink:href="abd-90-06-0888-g05"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>EHK has an autosomal dominant inheritance pattern with complete penetrance,
although there are some reports of recessive inheritance.<sup><xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref></sup> The genetic mutation occurs in the gene that codifies
cytokeratin 1 (CK1) and/or cytokeratin 10 (CK10), located in chromosomes
17q12-21 and 12q11-13, respectively. These cytokeratins are fundamental
components of the cytoskeleton and are expressed in the suprabasal layers of
keratinized stratified epithelial tissue. A deficitary cytoskeleton breaks
easily, leading to a bullous feature clinically observed in the first months of
life. Cytokeratins 1 and 10 have a role in inhibiting cell proliferation,
therefore the hyperkeratosis observed would arise from this insufficient
inhibition as much as from stimuli of cytokines released during cell
rupture.</p>
      <p>More severe forms are observed involving the palmoplantar regions in patients with
CK1 alterations, in comparison with CK10 mutations. These are represented by
milder symptoms, which are usually distributed along Blaschko lines.<sup><xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r3" ref-type="bibr">3</xref></sup></p>
      <p>At birth lesions present with erythrodermia, desquamation and superficial fragile
blisters. During the first weeks the skin acquires the typical aspect of the
disease, with hyperkeratosis, dark and very thick scales. Palmoplantar
keratodermia can be observed, as well as joint contractures secondary to
predominance of lesions in flexural areas. Adnexae are generally spared and
there is no involvement of internal viscera.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref></sup></p>
      <p>There are several forms of clinical presentation. Some classifications were
proposed, and since it is a spectral disease, EHK may be classified under the
group of ichthyosiform diseases as well as in the group of epidermal nevi. <xref ref-type="table" rid="t1">Table 1</xref> divides a sample of patients with
EHK into 2 large groups in which the presence or absence of palmoplantar
hyperkeratosis is the main distinctive characteristic that distinguishes the
groups. The patient of this case report would be classified as NPS2.</p>
      <table-wrap id="t1" orientation="portrait" position="float">
        <label>Table 1</label>
        <caption>
          <p>Clinical characteristics of the main subgroups of epidermolytic
hyperkeratosis</p>
        </caption>
        <table frame="hsides" rules="groups">
          <thead>
            <tr>
              <th rowspan="1" colspan="1">&#xA0;</th>
              <th rowspan="1" colspan="1">NPS - 1</th>
              <th rowspan="1" colspan="1">NPS - 2</th>
              <th rowspan="1" colspan="1">NPS - 3</th>
              <th rowspan="1" colspan="1">PS - 1</th>
              <th rowspan="1" colspan="1">PS - 2</th>
              <th rowspan="1" colspan="1">PS - 3</th>
            </tr>
            <tr>
              <th rowspan="1" colspan="1">&#xA0;</th>
              <th rowspan="1" colspan="1">N 11</th>
              <th rowspan="1" colspan="1">N7</th>
              <th rowspan="1" colspan="1">N5</th>
              <th rowspan="1" colspan="1">N25</th>
              <th rowspan="1" colspan="1">N3</th>
              <th rowspan="1" colspan="1">N1</th>
            </tr>
          </thead>
          <tbody>
            <tr>
              <td rowspan="1" colspan="1">Plamar-plantar hyperkeratosis</td>
              <td rowspan="1" colspan="1">-</td>
              <td rowspan="1" colspan="1">-</td>
              <td rowspan="1" colspan="1">-</td>
              <td rowspan="1" colspan="1">+</td>
              <td rowspan="1" colspan="1">+</td>
              <td rowspan="1" colspan="1">+</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Palmar-plantar surface</td>
              <td rowspan="1" colspan="1">Normal</td>
              <td rowspan="1" colspan="1">Normal</td>
              <td rowspan="1" colspan="1">Superlinear, minimal flaking</td>
              <td rowspan="1" colspan="1">Flat</td>
              <td rowspan="1" colspan="1">Flat</td>
              <td rowspan="1" colspan="1">Cerebriform</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Digital contractures</td>
              <td rowspan="1" colspan="1">-</td>
              <td rowspan="1" colspan="1">-</td>
              <td rowspan="1" colspan="1">-</td>
              <td rowspan="1" colspan="1">-</td>
              <td rowspan="1" colspan="1">+</td>
              <td rowspan="1" colspan="1">-</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Flaking</td>
              <td rowspan="1" colspan="1">Hystrix</td>
              <td rowspan="1" colspan="1">Brown</td>
              <td rowspan="1" colspan="1">Thin, white</td>
              <td rowspan="1" colspan="1">Soft</td>
              <td rowspan="1" colspan="1">White, rough</td>
              <td rowspan="1" colspan="1">Brownish</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Distribution</td>
              <td rowspan="1" colspan="1">General</td>
              <td rowspan="1" colspan="1">General</td>
              <td rowspan="1" colspan="1">General</td>
              <td rowspan="1" colspan="1">Local</td>
              <td rowspan="1" colspan="1">General</td>
              <td rowspan="1" colspan="1">General</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Erythroderma</td>
              <td rowspan="1" colspan="1">-</td>
              <td rowspan="1" colspan="1">-</td>
              <td rowspan="1" colspan="1">+</td>
              <td rowspan="1" colspan="1">-</td>
              <td rowspan="1" colspan="1">+</td>
              <td rowspan="1" colspan="1">-</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Blisters</td>
              <td rowspan="1" colspan="1">+</td>
              <td rowspan="1" colspan="1">+</td>
              <td rowspan="1" colspan="1">+</td>
              <td rowspan="1" colspan="1">Local</td>
              <td rowspan="1" colspan="1">+</td>
              <td rowspan="1" colspan="1">Neonatal</td>
            </tr>
            <tr>
              <td rowspan="1" colspan="1">Abnormal posture (n of affected patients)</td>
              <td rowspan="1" colspan="1">1</td>
              <td rowspan="1" colspan="1">0</td>
              <td rowspan="1" colspan="1">3</td>
              <td rowspan="1" colspan="1">0</td>
              <td rowspan="1" colspan="1">2</td>
              <td rowspan="1" colspan="1">0</td>
            </tr>
          </tbody>
        </table>
        <table-wrap-foot>
          <fn id="TFN01">
            <p><bold>Source:</bold> Ross, et al., 2008<sup><xref rid="r4" ref-type="bibr">4</xref></sup></p>
          </fn>
        </table-wrap-foot>
      </table-wrap>
      <p>The histology allowed the observation of orthokeratotic hyperkeratosis,
papillomatosis, hypergranulosis, acanthosis, vacuolization of granulosa and
malpighian cells, and keratohyalin granules dispersed in the vacuolated granular
layer.<sup><xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r4" ref-type="bibr">4</xref></sup></p>
      <p>Diagnosis is done clinically, histopathologically and sometimes through molecular
biology. In the initial phases a differential diagnosis with bullous
epidermolises, staphylococcal scalded skin syndrome and toxic epidermal
necrolysis can be done. In hyperkeratotic phases, other ichthyoses are
considered while in localized forms, epidermal nevi are considered.</p>
      <p>The treatment includes topical keratolytics like urea (10% to 20%), emollients,
propylene glycol associated with lactic acid 5%, topical retinoids and liarozole
5% (inhibitor of retinoic acid metabolism); salt immersion baths and hydration
may be used.<sup><xref rid="r5" ref-type="bibr">5</xref></sup> Another option is
the topical use of calcipotriol hydrate + betamethasone dipropionate once a day
on lesions, at a maximum of 100g per week.<sup><xref rid="r6" ref-type="bibr">6</xref>,<xref rid="r7" ref-type="bibr">7</xref></sup> Use of PUVA
should be avoided due to increased risk of non-melanoma skin cancer.<sup><xref rid="r8" ref-type="bibr">8</xref></sup> In some periods the use of
topical antibiotics for <italic>staphylococcus aureus</italic> and antiseptic
soaps may be necessary.<sup><xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r5" ref-type="bibr">5</xref></sup></p>
      <p>Acitretin is the main drug used in generalized cases at a dose of
0.5-1mg/Kg/day.<sup><xref rid="r5" ref-type="bibr">5</xref>,<xref rid="r8" ref-type="bibr">8</xref>,<xref rid="r9" ref-type="bibr">9</xref>,<xref rid="r10" ref-type="bibr">10</xref></sup> The best
response was noticed in patients with CK10 mutation gene, that is, without
palmoplantar alterations and with significant improvement in quality of
life.<sup><xref rid="r1" ref-type="bibr">1</xref>,<xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r9" ref-type="bibr">9</xref></sup> The mechanism of action of retinoids is still obscure.
It seems to generate mutations in the expression of suprabasal keratins involved
in EHK.<sup><xref rid="r10" ref-type="bibr">10</xref></sup> The use of liarozole
cream appears to provide therapeutic benefits and to be safe but its advantage
over acitretin is uncertain.<sup><xref rid="r7" ref-type="bibr">7</xref></sup></p>
      <p>Continuously monitoring of long-term use of oral retinoid is necessary due to
skeletal and dyslipidemic abnormalities already reported.<sup><xref rid="r2" ref-type="bibr">2</xref>,<xref rid="r9" ref-type="bibr">9</xref></sup></p>
      <p>Epidermolytic hyperkeratosis is a rare disease that compromises the quality of
life of the patient, for the epidermis works as an interface between the
individual and the environment. This case report emphasizes early diagnosis,
possible differential diagnoses and discusses the most up-to-date
therapeutics.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="supported-by">
        <p>Financial Support: None</p>
      </fn>
      <fn fn-type="other">
        <p>How to cite this article: Hayashida MT, Mitsui GL, Reis NI, Fantinato G,
Jord&#xE3;o DN, Mercante AMC. Hyperkeratosis epidermolytic: a case report. An
Bras Dermatol. 2015;90(6):888-91.</p>
      </fn>
      <fn id="fn1" fn-type="other">
        <label>*</label>
        <p>Study carried out at Hospital Heliop&#xF3;lis - S&#xE3;o Paulo (SP), Brazil.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="r1">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kariya</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Jabur</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Cestari</surname>
              <given-names>SCP</given-names>
            </name>
            <name>
              <surname>Enokihara</surname>
              <given-names>MMSS</given-names>
            </name>
            <name>
              <surname>Michalany</surname>
              <given-names>NS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Hiperqueratose epidermol&#xED;tica: relato de caso e revis&#xE3;o da
classifica&#xE7;&#xE3;o</article-title>
          <source>An Bras Dermatol</source>
          <year>1998</year>
          <volume>73</volume>
          <fpage>321</fpage>
          <lpage>326</lpage>
        </element-citation>
      </ref>
      <ref id="r2">
        <label>2</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Sens</surname>
              <given-names>MM</given-names>
            </name>
          </person-group>
          <source>Hiperqueratose epidermol&#xED;tica em g&#xEA;meas monozig&#xF3;ticas: relato de
caso e revis&#xE3;o de literatura</source>
          <comment>monografia</comment>
          <publisher-loc>Florian&#xF3;polis, SC</publisher-loc>
          <publisher-name>Universidade Federal de Santa Catarina</publisher-name>
          <year>2007</year>
        </element-citation>
      </ref>
      <ref id="r3">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mendes</surname>
              <given-names>MS</given-names>
            </name>
            <name>
              <surname>Kouzak</surname>
              <given-names>SS</given-names>
            </name>
            <name>
              <surname>Aquino</surname>
              <given-names>TA</given-names>
            </name>
            <name>
              <surname>Takano</surname>
              <given-names>GH</given-names>
            </name>
            <name>
              <surname>Lima Ade</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Mosaic epidermolytic ichthyosis: case report</article-title>
          <source>An Bras Dermatol</source>
          <year>2013</year>
          <volume>88</volume>
          <fpage>116</fpage>
          <lpage>119</lpage>
          <pub-id pub-id-type="pmid">24346896</pub-id>
        </element-citation>
      </ref>
      <ref id="r4">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ross</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>DiGiovanna</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Capaldi</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Argenyi</surname>
              <given-names>Z</given-names>
            </name>
            <name>
              <surname>Fleckman</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Robinson-Bostom</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Histopathologic characterization of epidermolytic
hyperkeratosis: A systematic review of histology from the National
Registry for Ichthyosis and Related Skin Disorders</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2008</year>
          <volume>59</volume>
          <fpage>86</fpage>
          <lpage>90</lpage>
          <pub-id pub-id-type="pmid">18571597</pub-id>
        </element-citation>
      </ref>
      <ref id="r5">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Traupe</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Burgdorf</surname>
              <given-names>WHC</given-names>
            </name>
          </person-group>
          <article-title>Treatment of ichthyosis: There is always something you can
do! In Memoriam: Wolfgang K&#xFC;ster</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2007</year>
          <volume>57</volume>
          <fpage>542</fpage>
          <lpage>547</lpage>
        </element-citation>
      </ref>
      <ref id="r6">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kohn</surname>
              <given-names>MJA</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>Jss</given-names>
            </name>
            <name>
              <surname>Chong</surname>
              <given-names>WS</given-names>
            </name>
          </person-group>
          <article-title>Systematized epidermal nevus with epidermolytic
hyperkeratosis improving with topical calcipotriol/betametasone
dipropionate combination ointment</article-title>
          <source>Pediatr Dermatol</source>
          <year>2013</year>
          <volume>30</volume>
          <fpage>370</fpage>
          <lpage>373</lpage>
          <pub-id pub-id-type="pmid">22938157</pub-id>
        </element-citation>
      </ref>
      <ref id="r7">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hern&#xE1;ndez-Martin</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Aranegui</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Martin-Santiago</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Garcia-Doval</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>A systematic review of clinical trials of treatments for the
congenital ichthyosis, excluding ichthyosis vulgaris</article-title>
          <source>J Am Acad Dermatol</source>
          <year>2013</year>
          <volume>69</volume>
          <fpage>544</fpage>
          <lpage>549</lpage>
          <elocation-id/>
          <pub-id pub-id-type="pmid">23870202</pub-id>
        </element-citation>
      </ref>
      <ref id="r8">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sarnoff</surname>
              <given-names>DS</given-names>
            </name>
            <name>
              <surname>Saini</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Multiple nonmelanoma skin cancers in a patient with
epidermolytic hyperkeratosis on long-standing retinoid
therapy</article-title>
          <source>J Drugs Dermatol</source>
          <year>2008</year>
          <volume>7</volume>
          <fpage>475</fpage>
          <lpage>478</lpage>
          <pub-id pub-id-type="pmid">18505142</pub-id>
        </element-citation>
      </ref>
      <ref id="r9">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nassif</surname>
              <given-names>PW</given-names>
            </name>
            <name>
              <surname>Nakandakari</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Fogagnolo</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Contin</surname>
              <given-names>LA</given-names>
            </name>
            <name>
              <surname>Alves</surname>
              <given-names>CJ</given-names>
            </name>
          </person-group>
          <article-title>Hiperceratose epidermol&#xED;tica: um seguimento de 23 anos de
uso de retin&#xF3;ides orais</article-title>
          <source>An Bras Dermatol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>S72</fpage>
          <lpage>S75</lpage>
          <pub-id pub-id-type="pmid">22068776</pub-id>
        </element-citation>
      </ref>
      <ref id="r10">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>T&#xF6;rm&#xE4;</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Retinoids reduce formation of keratin aggregates
Heat-stressed immortalized keratinocytes from an epidermolytic
ichthyosis patient with a KRT10 mutation</article-title>
          <source>Acta Derm Venereol</source>
          <year>2013</year>
          <volume>93</volume>
          <fpage>44</fpage>
          <lpage>49</lpage>
          <pub-id pub-id-type="pmid">22504942</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f2" orientation="portrait" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Detail of left axilla affected by verrucous plaques that follow Blaschko
lines</p>
      </caption>
      <graphic xlink:href="abd-90-06-0888-g02"/>
    </fig>
    <fig id="f3" orientation="portrait" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Verrucous plaques grouped on left elbow</p>
      </caption>
      <graphic xlink:href="abd-90-06-0888-g03"/>
    </fig>
  </floats-group>
</article>
</pmc-articleset>
